Abhumka Herbal Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-07-2024
- Paid Up Capital ₹ 0.10 M
as on 08-07-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2020
- Revenue -86.17%
(FY 2019)
- Profit -88.33%
(FY 2019)
- Ebitda -144.65%
(FY 2019)
- Net Worth -35.94%
(FY 2019)
- Total Assets -32.50%
(FY 2019)
About Abhumka Herbal
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhagyesh Soneji, Manish Singh, and Deepak Acharya serve as directors at the Company.
- CIN/LLPIN
U24233GJ2007PTC050322
- Company No.
050322
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Mar 2007
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Abhumka Herbal Private Limited offer?
Abhumka Herbal Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Cholesterol Medicine, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Ayurvedic Herbal Syrups & Tonics, Ayurvedic & Herbal Health Supplement, Herbal Supplements, Mosquito & Insect Repellent, Mosquito Repellent, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Abhumka Herbal?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Acharya  | Director | 22-Mar-2007 | Current |
| Bhagyesh Soneji | Director | Current | |
| Manish Singh | Director | 22-Mar-2007 | Current |
Financial Performance of Abhumka Herbal.
Abhumka Herbal Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 86.17% decrease. The company also saw a substantial fall in profitability, with a 88.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 35.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abhumka Herbal?
In 2019, Abhumka Herbal had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Abhumka Herbal?
Unlock and access historical data on people associated with Abhumka Herbal, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abhumka Herbal, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abhumka Herbal's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
